4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF

This study has been completed.
Sponsor:
Collaborator:
AGO Germany
Information provided by (Responsible Party):
West German Study Group
ClinicalTrials.gov Identifier:
NCT02115204
First received: April 8, 2014
Last updated: June 18, 2015
Last verified: June 2015